Remove Clinical Development Remove Clinical Research Remove Drug Trials
article thumbnail

Building Inclusive Trials: Insights from CTTI’s Diversity Initiatives

XTalks

The Clinical Trials Transformation Initiative (CTTI) aims to change this narrative by developing recommendations and driving the adoption of practices that support inclusivity and representativeness of all patient populations in clinical research.

Trials 52
article thumbnail

Steps to building a more patient-centric industry

pharmaphorum

A recent survey of clinical trial professionals found that more than two-thirds of respondents (61%) believe giving patients choice will have a positive impact on clinical research, and well over half (58%) said that their organisations plan to give patients the option to choose how they participate in clinical trials moving forward.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

This week in drug discovery (6-10 February)

Drug Discovery World

Clinical drug trials have made the headlines this week, as it was revealed that breast cancer still tops the bill for number of clinical studies and the shortcomings in current methods to ensure representation of patient populations in trials were exposed.

Drugs 52
article thumbnail

Unlocking the potential in rare disease research with decentralised trials

pharmaphorum

A few others said they would struggle to comprehend all the trial literature on their own. What does this mean for clinical trials in the future? One of the barriers to uptake of virtual trials in the past has been the assumption that it requires a fully decentralised approach. Conclusion.

Trials 133